EBIT Margin: Earnings before interest and taxes as a portion of total revenues. Calculated as: EBIT / Total Revenues
Lifecore Biomedical, Inc. (LFCR) had EBIT Margin of -13.38% for the most recently reported fiscal year, ending 2025-05-31.
| Income Statement Financials | |
$128.87M |
|
$-44.36M |
|
$88.57M |
|
$40.30M |
|
$146.11M |
|
$-17.25M |
|
$-21.43M |
|
$-38.67M |
|
$-38.67M |
|
$-38.72M |
|
$-38.72M |
|
$-38.72M |
|
$-38.72M |
|
$-17.25M |
|
$-9.22M |
|
34.82M |
|
34.82M |
|
$-1.27 |
|
$-1.27 |
|
| Balance Sheet Financials | |
$85.68M |
|
$129.01M |
|
$153.66M |
|
$239.34M |
|
$30.18M |
|
$151.99M |
|
$161.73M |
|
$191.91M |
|
$1.34M |
|
$29.35M |
|
$47.43M |
|
37.03M |
|
| Cash Flow Statement Financials | |
$-0.21M |
|
$-6.42M |
|
$6.42M |
|
$8.46M |
|
$8.27M |
|
$-0.20M |
|
$10.16M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.84 |
|
-- |
|
-- |
|
0.76 |
|
3.20 |
|
31.27% |
|
-13.38% |
|
|
EBIT Margin |
-13.38% |
-7.15% |
|
-30.01% |
|
-34.42% |
|
$-6.62M |
|
-- |
|
-- |
|
-- |
|
0.54 |
|
2.74 |
|
4.49 |
|
81.26 |
|
-2897.98% |
|
-131.91% |
|
-16.18% |
|
-19.41% |
|
$1.28 |
|
$-0.19 |
|
$-0.01 |
|